Melatonin Intervention to Prevent Delirium in Hospitalized Patients: A Meta-analysis

Overview

Journal World J Clin Cases

Publisher Baishideng Publishing Group

Specialty General Medicine

Date 2022 Jun 1

PMID 35647160

Authors

Wei You

Xiao-Yu Fan

Cheng Lei

Chen-Cong Nie

Yao Chen

Xue-Lian Wang

Affiliations

Soon will be listed here.

Abstract

Background: Evaluation of the effectiveness of melatonin is necessary to prevent the development of delirium in hospitalized patients. Melatonin (N-acetyl-5-methoxytryptamine) is a hormone produced by the pineal gland of the brain from the amino acid tryptophan. Synthetic melatonin supplements have been used for various medical conditions, especially sleep-related diseases, and have proved to be successful.

Aim: To determine the effect of melatonin on the prevention of delirium in hospitalized patients.

Methods: A literature search of the CNKI, Wanfang Database, VIP Database, China Biomedical Literature Database, PubMed, Embase, Cochrane Library, Web of Science, and other databases was conducted. The CNKI, Wanfang Database, VIP Database (VIP), and China Biomedical Literature Database were searched for Chinese studies, and PubMed, Embase, Cochrane Library, Web of Science and other databases were searched for international studies. It will be established in June 2021 in a randomized controlled trial (RCT) whether melatonin treatment for 6 mo prevents delirium in hospitalized patients. Literature screening, quality review, and data extraction were carried out using the Cochrane Manual 5.1.0 systematic evaluation method, and Stata 15.0 software and Review Manager 5.3 were used for meta-analysis and processing.

Results: A total of 18 new RCT articles and 18 experimental subjects were identified. The results of the meta-analysis showed that following the occurrence of delirium, melatonin reduced the incidence of delirium in patients (RR = 0.69, 95%CI: 0.60-0.80), which is of significance, but heterogeneity was significant = 62%. Subgroup analysis was performed to examine the source of heterogeneity, and it was found that different patient types were the source of heterogeneity; the research on subgroup analysis was of high quality and homogeneous. To determine the reliability and robustness of the research results, a sensitivity analysis was carried out. The results showed that after excluding individual studies one by one, the effect size was still within 95%CI, which strengthened the reliability of the original meta-analysis results. Melatonin has a significant preventive effect on delirium in hospitalized medical patients [RR = 0.60, 95%CI: 0.47-0.76), < 0.001].

Conclusion: Melatonin can reduce the rate of delirium in medical patients, and the role of melatonin in reducing the incidence of delirium in surgical patients and critical care unit patients requires further study.

Citing Articles

Effects of melatonin on the prevention of delirium in hospitalized older patients: systematic review and meta-analysis.

Liu L, Ma X, Song Z, Li J, Zhao Y, Meng C BMC Pharmacol Toxicol. 2024; 25(1):90.

PMID: 39587681 PMC: 11587658. DOI: 10.1186/s40360-024-00816-9.

Delirium and sleep disturbances-A narrative review.

Kuhlmann J, Alhammadi E, Mevissen A, Mollmann H Z Gerontol Geriatr. 2023; 56(7):539-544.

PMID: 37665376 DOI: 10.1007/s00391-023-02228-6.

Enhancing circadian rhythms-the circadian MEGA bundle as novel approach to treat critical illness.

Prin M, Bertazzo J, Walker L, Scott B, Eckle T Ann Transl Med. 2023; 11(9):319.

PMID: 37404989 PMC: 10316098. DOI: 10.21037/atm-22-5127.

Melatonin's actions are not limited to sleep.

Venaki E, Koukkou E, Ilias I World J Exp Med. 2023; 13(2):4-6.

PMID: 36970311 PMC: 10037225. DOI: 10.5493/wjem.v13.i2.4.

References

Lawlor P, McNamara-Kilian M, MacDonald A, Momoli F, Tierney S, Lacaze-Masmonteil N . Melatonin to prevent delirium in patients with advanced cancer: a double blind, parallel, randomized, controlled, feasibility trial. BMC Palliat Care. 2020; 19(1):163. PMC: 7579814. DOI: 10.1186/s12904-020-00669-z. View

Irwin S, Pirrello R, Hirst J, Buckholz G, Ferris F . Clarifying delirium management: practical, evidenced-based, expert recommendations for clinical practice. J Palliat Med. 2013; 16(4):423-35. PMC: 3612281. DOI: 10.1089/jpm.2012.0319. View

Mo Y, Scheer C, Abdallah G . Emerging Role of Melatonin and Melatonin Receptor Agonists in Sleep and Delirium in Intensive Care Unit Patients. J Intensive Care Med. 2015; 31(7):451-5. DOI: 10.1177/0885066615592348. View

Nishikimi M, Numaguchi A, Takahashi K, Miyagawa Y, Matsui K, Higashi M . Effect of Administration of Ramelteon, a Melatonin Receptor Agonist, on the Duration of Stay in the ICU: A Single-Center Randomized Placebo-Controlled Trial. Crit Care Med. 2018; 46(7):1099-1105. PMC: 6012040. DOI: 10.1097/CCM.0000000000003132. View

Hatta K, Kishi Y, Wada K, Takeuchi T, Odawara T, Usui C . Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. JAMA Psychiatry. 2014; 71(4):397-403. DOI: 10.1001/jamapsychiatry.2013.3320. View

Inouye S, van Dyck C, Alessi C, Balkin S, Siegal A, Horwitz R . Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990; 113(12):941-8. DOI: 10.7326/0003-4819-113-12-941. View

Al-Aama T, Brymer C, Gutmanis I, Woolmore-Goodwin S, Esbaugh J, Dasgupta M . Melatonin decreases delirium in elderly patients: a randomized, placebo-controlled trial. Int J Geriatr Psychiatry. 2010; 26(7):687-94. DOI: 10.1002/gps.2582. View

Michaud L, Bula C, Berney A, Camus V, Voellinger R, Stiefel F . Delirium: guidelines for general hospitals. J Psychosom Res. 2007; 62(3):371-83. DOI: 10.1016/j.jpsychores.2006.10.004. View

Carter G, Dawson A, Lopert R . Drug-induced delirium. Incidence, management and prevention. Drug Saf. 1996; 15(4):291-301. DOI: 10.2165/00002018-199615040-00007. View

10.

Mengel A, Zurloh J, Bosselmann C, Brendel B, Stadler V, Sartor-Pfeiffer J . Delirium REduction after administration of melatonin in acute ischemic stroke (DREAMS): A propensity score-matched analysis. Eur J Neurol. 2021; 28(6):1958-1966. DOI: 10.1111/ene.14792. View

11.

Jaiswal S, Vyas A, Heisel A, Ackula H, Aggarwal A, Kim N . Ramelteon for Prevention of Postoperative Delirium: A Randomized Controlled Trial in Patients Undergoing Elective Pulmonary Thromboendarterectomy. Crit Care Med. 2019; 47(12):1751-1758. PMC: 6861685. DOI: 10.1097/CCM.0000000000004004. View

12.

Abbasi S, Farsaei S, Ghasemi D, Mansourian M . Potential Role of Exogenous Melatonin Supplement in Delirium Prevention in Critically Ill Patients: A Double-Blind Randomized Pilot Study. Iran J Pharm Res. 2018; 17(4):1571-1580. PMC: 6269584. View

13.

Bush S, Lawlor P, Ryan K, Centeno C, LUCCHESI M, Kanji S . Delirium in adult cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2018; 29(Suppl 4):iv143-iv165. DOI: 10.1093/annonc/mdy147. View

14.

Inouye S . The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. Am J Med. 1994; 97(3):278-88. DOI: 10.1016/0002-9343(94)90011-6. View

15.

Lawlor P, Bush S . Delirium in patients with cancer: assessment, impact, mechanisms and management. Nat Rev Clin Oncol. 2014; 12(2):77-92. DOI: 10.1038/nrclinonc.2014.147. View

16.

Seifman M, Gomes K, Nguyen P, Bailey M, Rosenfeld J, Cooper D . Measurement of serum melatonin in intensive care unit patients: changes in traumatic brain injury, trauma, and medical conditions. Front Neurol. 2014; 5:237. PMC: 4235080. DOI: 10.3389/fneur.2014.00237. View

17.

Oh E, Leoutsakos J, Rosenberg P, Pletnikova A, Khanuja H, Sterling R . Effects of Ramelteon on the Prevention of Postoperative Delirium in Older Patients Undergoing Orthopedic Surgery: The RECOVER Randomized Controlled Trial. Am J Geriatr Psychiatry. 2020; 29(1):90-100. PMC: 8809889. DOI: 10.1016/j.jagp.2020.05.006. View

18.

Cipolla-Neto J, do Amaral F . Melatonin as a Hormone: New Physiological and Clinical Insights. Endocr Rev. 2018; 39(6):990-1028. DOI: 10.1210/er.2018-00084. View

19.

Agar M, Lawlor P, Quinn S, Draper B, Caplan G, Rowett D . Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical Trial. JAMA Intern Med. 2016; 177(1):34-42. DOI: 10.1001/jamainternmed.2016.7491. View

20.

Witlox J, Eurelings L, de Jonghe J, Kalisvaart K, Eikelenboom P, van Gool W . Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA. 2010; 304(4):443-51. DOI: 10.1001/jama.2010.1013. View